130 related articles for article (PubMed ID: 19917276)
1. The putative lipid raft modulator miltefosine displays immunomodulatory action in T-cell dependent dermal inflammation models.
Bäumer W; Wlaź P; Jennings G; Rundfeldt C
Eur J Pharmacol; 2010 Feb; 628(1-3):226-32. PubMed ID: 19917276
[TBL] [Abstract][Full Text] [Related]
2. Long-term reduction in local inflammation by a lipid raft molecule in atopic dermatitis.
Dölle S; Hoser D; Rasche C; Loddenkemper C; Maurer M; Zuberbier T; Worm M
Allergy; 2010 Sep; 65(9):1158-65. PubMed ID: 20337610
[TBL] [Abstract][Full Text] [Related]
3. The phosphodiesterase 4 inhibitor AWD 12-281 is active in a new guinea-pig model of allergic skin inflammation predictive of human skin penetration and suppresses both Th1 and Th2 cytokines in mice.
Hoppmann J; Bäumer W; Galetzka C; Höfgen N; Kietzmann M; Rundfeldt C
J Pharm Pharmacol; 2005 Dec; 57(12):1609-17. PubMed ID: 16354405
[TBL] [Abstract][Full Text] [Related]
4. Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial.
Hartmann K; Siebenhaar F; Belloni B; Brockow K; Eben R; Hartmann B; Ruëff F; Schoepke N; Staubach P; Weber A; Maurer M
Br J Dermatol; 2010 Jan; 162(1):185-90. PubMed ID: 19785605
[TBL] [Abstract][Full Text] [Related]
5. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
Aguiar MG; Silva DL; Nunan FA; Nunan EA; Fernandes AP; Ferreira LA
J Antimicrob Chemother; 2009 Dec; 64(6):1234-40. PubMed ID: 19825819
[TBL] [Abstract][Full Text] [Related]
6. AWD 12-281, a highly selective phosphodiesterase 4 inhibitor, is effective in the prevention and treatment of inflammatory reactions in a model of allergic dermatitis.
Bäumer W; Gorr G; Hoppmann J; Ehinger AM; Rundfeldt C; Kietzmann M
J Pharm Pharmacol; 2003 Aug; 55(8):1107-14. PubMed ID: 12956900
[TBL] [Abstract][Full Text] [Related]
7. Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response.
Wadhone P; Maiti M; Agarwal R; Kamat V; Martin S; Saha B
J Immunol; 2009 Jun; 182(11):7146-54. PubMed ID: 19454711
[TBL] [Abstract][Full Text] [Related]
8. Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits type I-IV allergic inflammation and pro-inflammatory enzymes.
Lee JY; Kim CJ
Arch Pharm Res; 2010 Jun; 33(6):947-57. PubMed ID: 20607501
[TBL] [Abstract][Full Text] [Related]
9. Topical anti-inflammatory effect of Caryocar coriaceum Wittm. (Caryocaraceae) fruit pulp fixed oil on mice ear edema induced by different irritant agents.
Saraiva RA; Araruna MK; Oliveira RC; Menezes KD; Leite GO; Kerntopf MR; Costa JG; Rocha JB; Tomé AR; Campos AR; Menezes IR
J Ethnopharmacol; 2011 Jul; 136(3):504-10. PubMed ID: 20621180
[TBL] [Abstract][Full Text] [Related]
10. Topically Administered Janus-Kinase Inhibitors Tofacitinib and Oclacitinib Display Impressive Antipruritic and Anti-Inflammatory Responses in a Model of Allergic Dermatitis.
Fukuyama T; Ehling S; Cook E; Bäumer W
J Pharmacol Exp Ther; 2015 Sep; 354(3):394-405. PubMed ID: 26159873
[TBL] [Abstract][Full Text] [Related]
11. Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling.
Chung YL; Pui NN
J Dermatol Sci; 2011 Dec; 64(3):163-73. PubMed ID: 21924869
[TBL] [Abstract][Full Text] [Related]
12. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
13. Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis.
Bäumer W; Sülzle B; Weigt H; De Vries VC; Hecht M; Tschernig T; Kietzmann M
Br J Dermatol; 2005 Jul; 153(1):136-44. PubMed ID: 16029339
[TBL] [Abstract][Full Text] [Related]
14. Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in mice.
Arai I; Takaoka A; Hashimoto Y; Honma Y; Koizumi C; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakanishi Y; Sakurai T; Tanami T; Yagi M; Ono N; Nakaike S
Eur J Pharmacol; 2007 Feb; 556(1-3):207-14. PubMed ID: 17141215
[TBL] [Abstract][Full Text] [Related]
15. Miltefosine effectively modulates the cytokine milieu in Indian post kala-azar dermal leishmaniasis.
Mukhopadhyay D; Das NK; Roy S; Kundu S; Barbhuiya JN; Chatterjee M
J Infect Dis; 2011 Nov; 204(9):1427-36. PubMed ID: 21933878
[TBL] [Abstract][Full Text] [Related]
16. Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis.
Terakawa M; Fujieda Y; Tomimori Y; Muto T; Tanaka T; Maruoka H; Nagahira K; Ogata A; Nakatsuka T; Fukuda Y
Eur J Pharmacol; 2008 Dec; 601(1-3):186-91. PubMed ID: 18996112
[TBL] [Abstract][Full Text] [Related]
17. Depletion of substance P, a mechanism for inhibition of mouse scratching behavior by tacrolimus.
Inagaki N; Shiraishi N; Igeta K; Nagao M; Kim JF; Chikumoto T; Itoh T; Katoh H; Tanaka H; Nagai H
Eur J Pharmacol; 2010 Jan; 626(2-3):283-9. PubMed ID: 19818345
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of Uncariae rhynchophylla inhibits the development of DNFB-induced atopic dermatitis-like skin lesions via IFN-gamma down-regulation in NC/Nga mice.
Kim DY; Jung JA; Kim TH; Seo SW; Jung SK; Park CS
J Ethnopharmacol; 2009 Apr; 122(3):567-72. PubMed ID: 19429328
[TBL] [Abstract][Full Text] [Related]
19. Pimecrolimus -- an anti-inflammatory drug targeting the skin.
Grassberger M; Steinhoff M; Schneider D; Luger TA
Exp Dermatol; 2004 Dec; 13(12):721-30. PubMed ID: 15560755
[TBL] [Abstract][Full Text] [Related]
20. Effects and mechanisms of aloperine on 2, 4-dinitrofluorobenzene-induced allergic contact dermatitis in BALB/c mice.
Yuan XY; Liu W; Zhang P; Wang RY; Guo JY
Eur J Pharmacol; 2010 Mar; 629(1-3):147-52. PubMed ID: 20006963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
